CHRISTINA BARLOW: Open Payments
NPI 1760621015 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,205 in 34 payments from 14 companies in 2025. Trend: 2023 $207 · 2024 $878 · 2025 $1,205
Food & beverage: $1,205
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 3 | $295 |
| ABBVIE INC. | 9 | $255 |
| Amgen Inc. | 8 | $186 |
| UCB, Inc. | 1 | $125 |
| Botanix SB Inc | 1 | $100 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $63 |
| PFIZER INC. | 2 | $50 |
| Lilly USA, LLC | 1 | $29 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $20 |
Products named: NEMLUVIO, SKYRIZI, OTEZLA, Bimzelx, SOFDRA, CIBINQO, EBGLYSS, SPEVIGO.
Industry payments across FL — which companies pay providers there.
